Plunkett Research Online: Amneal Pharmaceuticals Inc

AMNEAL PHARMACEUTICALS INC (AMRX:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products in a variety of dosage forms and therapeutic categories. Amneal is organized into two business segments: generic and specialty.....



Amneal Pharmaceuticals Inc
Ticker: AMRX
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 908-947-3120
Fax:
Address: 400 Crossing Boulevard
3rd Floor
Bridgewater, NJ 08807 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Drugs-Generic
Pharmaceutical Discovery & Development
Drugs-Central Nervous System
R&D Services
ContactsDescription
Robert StewartCEO/Director/President
Todd BranningCFO/Senior VP
See More
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products in a variety of dosage forms and therapeutic categories. Amneal is organized into two business segments: generic and specialty.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Rytary
Zomig
Emverm
Unithroid
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: